Shares of DexCom Inc. DXCM rose 5.86% to $70.78 Thursday, on what proved to be an all-around positive trading session for the ...

The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users.

In a head-to-head study, three continuous glucose monitoring systems showed different measurements in the same person, which ...

San Diego-based Dexcom, a leading diabetes technology company known for its wearable glucose monitors, is expanding its NIL ...

DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the return of Dexcom U – its ...

SAN DIEGO – Dexcom is bringing back Dexcom U, a name, image and license program for college athletes with diabetes.

SAN DIEGO, April 22, 2025--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the return of Dexcom U – its one-of-a-kind Name, Image and Likeness program ...

Shares of DexCom Inc. DXCM slid 3.59% to $66.11 Monday, on what proved to be an all-around rough trading session for the ...

Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...

The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.

What Johnson & Johnson and Eli Lilly are saying about Trump’s pharmaceutical tariffs, and Dexcom scores FDA approval for its ...